GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silexion Therapeutics Corp (NAS:SLXN) » Definitions » Other Long-Term Liabilities

SLXN (Silexion Therapeutics) Other Long-Term Liabilities : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Silexion Therapeutics Other Long-Term Liabilities?

Silexion Therapeutics's other long-term liabilities for the quarter that ended in Sep. 2024 was $0.00 Mil.

Silexion Therapeutics's quarterly other long-term liabilities stayed the same from Mar. 2024 ($15.06 Mil) to Jun. 2024 ($15.06 Mil) but then declined from Jun. 2024 ($15.06 Mil) to Sep. 2024 ($0.00 Mil).

Silexion Therapeutics's annual other long-term liabilities increased from . 20 ($0.00 Mil) to Dec. 2022 ($14.65 Mil) and increased from Dec. 2022 ($14.65 Mil) to Dec. 2023 ($15.06 Mil).

Silexion Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Silexion Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silexion Therapeutics Other Long-Term Liabilities Chart

Silexion Therapeutics Annual Data
Trend Dec22 Dec23
Other Long-Term Liabilities
- -

Silexion Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long-Term Liabilities Get a 7-Day Free Trial - - - - -

Silexion Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Silexion Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Silexion Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Silexion Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Silexion Therapeutics Corp (NAS:SLXN) » Definitions » Other Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
2 Ha mayan Street, Modi in-Maccabim-Reut, ISR, 7177871
Website
https://www.silexion.com
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.